Human Immunology News Volume 10.47 | Dec 6 2022

    0
    45








    2022-12-06 | HIN 10.47


    Human Immunology News by STEMCELL Technologies
    Vol. 10.47 – 6 December, 2022
    TOP STORY

    Inhaled Particulate Accumulation with Age Impairs Immune Function and Architecture in Human Lung Lymph Nodes

    In an analysis of human lymph nodes (LNs) from 84 organ donors aged 11–93 years, scientists found a specific age-related decline in lung-associated, but not gut-associated, LN immune function linked to the accumulation of inhaled atmospheric particulate matter.
    [Nature Medicine]

    Full ArticlePress Release
    ON1097CS-Wallchart-Natural-Killer-Cells-728x90
    PUBLICATIONSRanked by the impact factor of the journal

    CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

    Ten patients were treated with 36–165 x 106 CART19/20 cells. No patient experienced neurotoxicity of any grade, or over grade-1 cytokine release syndrome. One case of dose-limiting toxicity was observed.
    [Cancer Discovery]

    Abstract

    Phosphofructokinase P Fine-Tunes T Regulatory Cell Metabolism, Function, and Stability in Systemic Autoimmunity

    In Treg cells, a CRISPR-Cas9–enabled Pfkp deletion recapitulated the metabolism of Camk4−/− Treg cells, and improved their function and stability in vitro and in vivo.
    [Science Advances]

    Full Article

    Neuroimmune Transcriptome Changes in Patient Brains of Psychiatric and Neurological Disorders

    Scientitsts curated 1275 immune-related genes and investigated their expression changes in 2467 postmortem brains of controls and patients with six major brain disorders, including schizophrenia, bipolar disorder, autism spectrum disorder, major depressive disorder, Alzheimer’s disease, and Parkinson’s disease.
    [Molecular Psychiatry]

    Abstract

    Low-Dose IL-2 Reduces IL-21+ T Cell Frequency and Induces Anti-Inflammatory Gene Expression in Type 1 Diabetes

    Researchers examined the effects of interval administration of low-dose recombinant IL-2 in type 1 diabetes using high-resolution single-cell multiomics and flow cytometry on longitudinally-collected peripheral blood samples.
    [Nature Communications]

    Full Article

    Early Microbial Exposure Shapes Adult Immunity by Altering CD8+ T Cell Development

    Early microbial exposure resulted in the preferential expansion of highly responsive fetal-derived CD8+ T cells that persist into adulthood and provide the host with enhanced immune protection against intracellular pathogens.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article

    Identification of Common and Distinct Origins of Human Serum and Breastmilk IgA1 by Mass Spectrometry-Based Clonal Profiling

    Researchers assessed the structural diversity and clonal repertoire of IgA1-containing molecular assemblies longitudinally in human serum and milk from three donors using a mass spectrometry-based approach.
    [Cellular & Molecular Immunology]

    Full Article

    Tim-4 Reprograms Cholesterol Metabolism to Suppress Antiviral Innate Immunity by Disturbing the Insig1-SCAP Interaction in Macrophages

    Mechanistically, T cell immunoglobulin and mucin domain-containing molecule 4 (Tim-4) disturbed the Insig1-SCAP interaction and promoted SCAP-SREBP2 complex translocation to the Golgi apparatus.
    [Cell Reports]

    Full ArticleGraphical Abstract
    STEMCELL has implemented an Environmental Management System that is now ISO 14001-certified.
    REVIEWS

    Overcoming On-Target, Off-Tumor Toxicity of CAR T Cell Therapy for Solid Tumors

    Scientists summarize current clinical evidence of off-tumor toxicity (OTOT) with CAR T cells in the treatment of solid tumors and discuss the utility of preclinical mouse models in predicting clinical OTOT.
    [Nature Reviews Clinical Oncology]

    Abstract

    Gene Therapy for Inborn Errors of Immunity: Past, Present, and Future

    The author summarizes the journey of the past 25 years that has led to the successful use of gene therapy for Inborn errors of immunity and discusses the next steps for the field.
    [Nature Reviews Immunology]

    Full Article
    INDUSTRY AND POLICY NEWS

    BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates

    The two companies have entered into a multi-target research collaboration for several small molecule immunotherapy programs as well as an exclusive license agreement for Ryvu’s STING agonist portfolio as standalone small molecules.
    [BioNTech and Ryvu Therapeutics]

    Press Release

    Pyxis Oncology Announces FDA Clearance of Two IND Applications

    The FDA granted Investigational New Drug (IND) clearances of PYX-201, a novel antibody-drug conjugate product candidate, and PYX-106, an immunotherapy product candidate.
    [Pyxis Oncology, Inc.]

    Press Release
    FEATURED EVENT

    Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy

    January 29 – February 2, 2023
    Banff, Alberta, Canada

    > See All Events

    JOB OPPORTUNITIES

    PhD Positions – Biomedical Sciences

    Max Delbrück Center for Molecular Medicine – Berlin-Buch, Germany

    Senior Director – Therapeutic Area Quality

    Bristol Myers Squibb – Uxbridge, England, United Kingdom

    Research Associate – Immunology of Liver Disease

    The Ottawa Hospital – Ottawa, Ontario, Canada

    Research Assistant Professor – Lung Cancer Dissemination

    Albert Einstein College of Medicine – Bronx, New York, United States

    Director – Epidemiology, Vaccines, and Immune Therapies for Influenza

    AstraZeneca – Gothenburg, Sweden OR Gaithersburg or Wilmington, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Human Immunology News Twitter